As of December 15, 2025, Touchstone International Medical Science Co Ltd (688013.SS) reports a Net Margin of 18.44%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Touchstone International Medical Science Co Ltd's Net Margin
Over recent years, Touchstone International Medical Science Co Ltd's Net Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 18.44% |
| 2023-12-31 | 18.65% |
| 2022-12-31 | 18.62% |
| 2021-12-31 | 19.37% |
| 2020-12-31 | 21.37% |
This slight downward trend highlights how Touchstone International Medical Science Co Ltd manages its overall profitability and cost control over time.
Comparing Touchstone International Medical Science Co Ltd's Net Margin to Peers
To better understand Touchstone International Medical Science Co Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Touchstone International Medical Science Co Ltd (688013.SS) | 18.44% |
| Kangji Medical Holdings Ltd (9997.HK) | 57.65% |
| Shanghai MicroPort Endovascular MedTech Group Co Ltd (688016.SS) | 41.62% |
| Yestar Healthcare Holdings Co Ltd (2393.HK) | 38.24% |
| Beijing Succeeder Technology Inc (688338.SS) | 36.94% |
| Autek China Inc (300595.SZ) | 31.55% |
Compared to its competitors, Touchstone International Medical Science Co Ltd's Net Margin is about average compared to peers, reflecting typical industry profitability.